一个直肠膜血瘤的病例是由于自行注射 Certolizumab Pegol而引起的
Atsuhiko Suenaga1, Yuka Hashimoto2, Akiko Kanaya3
1Department of Nephrology, National Hospital Organization Ureshino Medical Center, Ureshino, JPN.
Cureus
|April 8, 2025
概括
这份病例报告详细介绍了使用Certolizumab pegol的患者的直肠血瘤 (RSH). 它强调了RSH的潜在风险因素,包括药物使用和患者的并发症.
科学领域:
- 胃肠病学和肝病学
- 放射学和成像学 放射学和成像学
- 类风湿病学 类风湿病学
背景情况:
- 直肠血瘤 (RSH) 是一种临床疾病,涉及直肠腹肌内出血.
- 它可以表现为腹痛,并与腹壁脂肪低,自动注射器使用和抗凝剂治疗等因素有关,特别是在末期功能衰竭和类风湿性关节炎患者中.
研究的目的:
- 报告与克尔科利祖马布佩戈尔注射相关的直肠血瘤 (RSH) 的第一个病例.
- 讨论在这个特定患者群体中可能导致RSH的潜在因素.
主要方法:
- 一个61岁的男性患者的案例研究,患有末期功能衰竭和类风湿性关节炎,出现腹痛.
- 使用计算机断层扫描 (CT) 进行诊断成像,以识别直肠血瘤.
- 干预性放射学手术,涉及由于疼痛升级而导致左下腹上动脉 (IEA) 的跨导管动脉栓塞 (TAE).
主要成果:
- 计算机断层扫描证实了一个大,高密度的左侧直肠膜血瘤.
- 通过导管动脉栓塞成功地进行了管理不断升级的腹痛.
- 这代表了首次记录的RSH与certollizumab pegol管理相关的案例.
结论:
- 塞尔科利祖马布佩戈尔 ( Certolizumab pegol),特别是当自己注射到腹壁时,可能是直肠血瘤的新奇原因.
- 临床医生应考虑在患有相关并发症 (末期功能衰竭,类风湿性关节炎) 和腹壁注射的患者中进行RSH,特别是在使用自动注射器设备时.
更多相关视频
09:41Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
14.7K
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.3K
相关概念视频
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
